Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown.
COVID-19
COVID-19 Restrictions
Parkinson’s disease
Physical activity
Quarantine
Rehabilitation
Social isolation
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
30 Aug 2021
30 Aug 2021
Historique:
received:
20
12
2020
accepted:
18
08
2021
entrez:
31
8
2021
pubmed:
1
9
2021
medline:
12
10
2021
Statut:
epublish
Résumé
The consequences of strict COVID-19 mobility restrictions on motor/non-motor features in Parkinson's disease (PD) have not been systematically studied but worse mobility and quality of life have been reported. To elucidate this question, 12 mild to moderate PD patients were assessed in March 2020 before and after two months of isolation as part of a clinical study that had to be interrupted due to the pandemic and the implementation of COVID19 mobility restrictions. Twelve patients were systematically evaluated before and after the lockdown period as part of a larger cohort that previously underwent thermal water rehabilitation. Clinical outcomes were the Body Mass index, the Mini-Balance Evaluation Systems Test, the MDS-Unified Parkinson's Disease Rating Scale part III, the 6 Minute Walking Test and the New Freezing of Gait Questionnaire. Global cognition was evaluated with the Montreal Cognitive Assessment scale. The impact of COVID-19 restrictions on quality of life and functional independence was evaluated with The Parkinson's disease Quality of life (PDQ-39), the Activities of Daily Living (ADL) and Instrumental Activities of Daily Living questionnaires (IADL) and the Parkinson's disease cognitive functional rating scales (PD-CFRS). After two months of isolation the Mini-BESTest score worsened (p=0.005), and four patients reported one or more falls during the lockdown. BMI increased (p=0.031) while the remaining clinical variables including quality of life did not change. We observed moderate worsening at Mini-BESTest, greater risk of falls and increased body weight as consequence of prolonged immobility. We believe negative effects were partially softened since patients were in contact with our multidisciplinary team during the lockdown and had previously received training to respond to the needs of this emergency isolation. These findings highligh the importnace of patient-centered interventions in PD management.
Sections du résumé
BACKGROUND
BACKGROUND
The consequences of strict COVID-19 mobility restrictions on motor/non-motor features in Parkinson's disease (PD) have not been systematically studied but worse mobility and quality of life have been reported. To elucidate this question, 12 mild to moderate PD patients were assessed in March 2020 before and after two months of isolation as part of a clinical study that had to be interrupted due to the pandemic and the implementation of COVID19 mobility restrictions.
METHODS
METHODS
Twelve patients were systematically evaluated before and after the lockdown period as part of a larger cohort that previously underwent thermal water rehabilitation. Clinical outcomes were the Body Mass index, the Mini-Balance Evaluation Systems Test, the MDS-Unified Parkinson's Disease Rating Scale part III, the 6 Minute Walking Test and the New Freezing of Gait Questionnaire. Global cognition was evaluated with the Montreal Cognitive Assessment scale. The impact of COVID-19 restrictions on quality of life and functional independence was evaluated with The Parkinson's disease Quality of life (PDQ-39), the Activities of Daily Living (ADL) and Instrumental Activities of Daily Living questionnaires (IADL) and the Parkinson's disease cognitive functional rating scales (PD-CFRS).
RESULTS
RESULTS
After two months of isolation the Mini-BESTest score worsened (p=0.005), and four patients reported one or more falls during the lockdown. BMI increased (p=0.031) while the remaining clinical variables including quality of life did not change.
CONCLUSION
CONCLUSIONS
We observed moderate worsening at Mini-BESTest, greater risk of falls and increased body weight as consequence of prolonged immobility. We believe negative effects were partially softened since patients were in contact with our multidisciplinary team during the lockdown and had previously received training to respond to the needs of this emergency isolation. These findings highligh the importnace of patient-centered interventions in PD management.
Identifiants
pubmed: 34461838
doi: 10.1186/s12883-021-02364-9
pii: 10.1186/s12883-021-02364-9
pmc: PMC8404403
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
332Informations de copyright
© 2021. The Author(s).
Références
Int J Geriatr Psychiatry. 2018 Dec;33(12):1736-1742
pubmed: 30246354
J Neurol Phys Ther. 2011 Jun;35(2):90-7
pubmed: 21934364
Neurodegener Dis Manag. 2014;4(3):203-21
pubmed: 25095816
Arch Phys Med Rehabil. 2017 Jul;98(7):1316-1324.e1
pubmed: 28254637
Occup Environ Med. 2014 May;71(5):358-65
pubmed: 24259677
Mov Disord. 2021 Jun;36(6):1287-1289
pubmed: 33890344
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Arch Phys Med Rehabil. 1986 Oct;67(10):741-5
pubmed: 3767624
Mov Disord. 2020 Jun;35(6):912-914
pubmed: 32304118
J Neurol. 1998 May;245 Suppl 1:S10-4
pubmed: 9617716
Mov Disord. 2020 Jun;35(6):905-908
pubmed: 32347572
Parkinsonism Relat Disord. 2014 Apr;20(4):394-9
pubmed: 24495708
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Mov Disord Clin Pract. 2020 Jul 17;:
pubmed: 32837960
J Am Med Dir Assoc. 2019 May;20(5):569-582.e7
pubmed: 30554987
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Parkinsonism Relat Disord. 2014 Nov;20(11):1236-41
pubmed: 25260967
J Neural Transm (Vienna). 2020 Mar;127(3):323-330
pubmed: 31898759
Parkinsonism Relat Disord. 2015 Dec;21(12):1421-6
pubmed: 26578041
J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445
pubmed: 31432258
Parkinsonism Relat Disord. 2013 Sep;19(9):812-7
pubmed: 23773412
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Lancet Neurol. 2020 Jul;19(7):623-634
pubmed: 32464101
Clin Rehabil. 2019 Dec;33(12):1949-1962
pubmed: 31571503
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
J Neural Transm (Vienna). 2017 Sep;124(9):1073-1081
pubmed: 28643101
Transl Neurodegener. 2015 Dec 10;4:24
pubmed: 26693006
BMC Neurol. 2014 Dec 12;14:235
pubmed: 25496796
Phys Ther. 2013 Apr;93(4):571-5
pubmed: 23547173
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
J Neurol. 2019 Mar;266(3):745-754
pubmed: 30635723
Brain. 2008 Aug;131(Pt 8):2094-105
pubmed: 18577547
Gait Posture. 2009 Nov;30(4):459-63
pubmed: 19660949
Phys Ther. 1989 Nov;69(11):944-55
pubmed: 2813522
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Expert Rev Neurother. 2021 Jun;21(6):615-623
pubmed: 33905283
Neurol Sci. 2013 May;34(5):683-7
pubmed: 22678179
J Alzheimers Dis. 2016 May 31;53(3):1107-14
pubmed: 27258421
Brain Pathol. 2010 May;20(3):646-53
pubmed: 20522090
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Phys Ther. 2008 Jun;88(6):733-46
pubmed: 18356292
Front Psychol. 2013 Nov 26;4:863
pubmed: 24324449
PLoS One. 2018 Feb 27;13(2):e0193113
pubmed: 29486000
PLoS One. 2018 Apr 12;13(4):e0195424
pubmed: 29649234
Arch Phys Med Rehabil. 2010 Sep;91(9):1332-8
pubmed: 20801249
Mov Disord. 2016 Sep;31(9):1342-55
pubmed: 26945525
J Neurol. 2005 Nov;252(11):1310-5
pubmed: 15895303
Neurol Sci. 2019 Apr;40(4):691-702
pubmed: 30637545
Parkinsonism Relat Disord. 2020 Sep;78:21-26
pubmed: 32674024